Inhibrx Biosciences INBX
NASDAQ INBX
$104.70 +2.99 (+2.94%)
As of: Sep 29, 2026 · 3:59 PM EDT

Inhibrx Biosciences (INBX) Net Margin (2023 - 2025)

Updated

Inhibrx Biosciences (INBX) recorded Net Margin of -10773.46% in FY2025, down 854559.46 percentage points from 843786.00% in FY2024.

Analysis

Inhibrx Biosciences (INBX) Net Margin (2023 - 2025) Analysis & Trends

  • Per Business Quant data, INBX's Net Margin was 843786.00% in FY2024 (+857194.94 pp) and -13408.94% in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 21.86%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 21.27%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -8.04%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 22.61%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 18.81%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 23.62%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -134.51%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -1.65%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 32.99%
10 Inhibrx Biosciences 1.50 Bn 1.50 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -2,204.15%
Dec 31, 2024 -47,865.00%
Jun 30, 2024 1,858,011.00%
Dec 31, 2023 -5,728.52%
Sep 30, 2023 -43,520.17%
Jun 30, 2023 -156,840.00%
API Access

Inhibrx Biosciences Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=INBX&period=max&api_key=YOUR_API_KEY